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Abstract. It is widely accepted that the immune system undergoes age-related
changes correlating with increased disease in the elderly. T cell subsets have been
implicated. The aim of this work is firstly to implement and validate a simulation
of T regulatory cell (Treg) dynamics throughout the lifetime, based on a model
by Baltcheva. We show that our initial simulation produces an inversion between
precursor and mature Tregs at around 20 years of age, though the output differs
significantly from the original laboratory dataset. Secondly, this report discusses
development of the model to incorporate new data from a cross-sectional study
of healthy blood donors addressing balance between Tregs and Th17 cells with
novel markers for Treg . The potential for simulation to add insight into immune
aging is discussed.
1 Introduction to System Dynamics Modelling of Immunity
Simulation has been defined as methods and applications mimicking the behaviour of
a real system [1]. The benefits of simulation to immunology include time- and cost-
effectiveness as well as less labour- and resource-intensiveness resulting from removal
from the biological environment. In vitro experimentation is useful for investigating
individual interactions but is far removed from the whole picture, and in vivo experi-
mentation is useful for the whole picture but is unlikely to answer specific questions
[2]. Using simulation, flexibility is available for systematically generating hypotheses
and conducting experiments impossible to do practically, yet informed by robust data
and literature.
System dynamics simulations are useful for looking at complex systems over time.
They are characterised by stocks of an entity and flows between stocks [3]. Immune
system examples of stocks include precursor and mature T cell pools and flows might
represent transition of cells from precursor to mature. This technique is useful for mod-
elling relationships defined by differential equations. An example of a differential equa-
tion describing T cell dynamics is the change in number of precursor cells equated to
proliferation of precursors minus death and maturation rates. This ongoing work will
apply system dynamics simulation technique to complement in vitro studies of Th17s
and Tregs throughout the lifetime.
2 The Need for Balance: Th17s and Tregs Throughout the Lifetime
The immune system maintains a balance between mounting an adequate immune re-
sponse to protect from infection and restricting the size of the immune response to
2prevent damage to self. There is evidence to suggest an age-related tendency to a pro-
inflammatory environment [4] contributing to more collateral damage and autoimmune
diseases. This work addresses the hypothesis that important contributors to this state
of imbalance are Th17 cells (amplifying immune responses) and Tregs (dampening
down immune responses). Although some studies have shown an age-related increase
in the number of Tregs in human peripheral blood [5][6], it has also been shown that
homeostasis is maintained [7]. One study concluded upon the oscillatory nature of Treg
numbers through life, with peaks in adolescence and in over 60 year olds [8]. A recent
study in Th17 cells with age showed a small decrease in the frequency of Th17 cells in
the CD4+ memory population in elderly donors relative to young [9]. However, for the
balance between Tregs and Th17 cells, there is currently no published literature.
There is evidence that the balance between Tregs and Th17s is altered in age-related
diseases such as acute coronary syndrome [10]. Thus it is intuitive that this balance
should be examined with a cross sectional study in healthy donors of different ages.
Laboratory experimentation will begin by using flow cytometry to enumerate peripheral
blood cells expressing CD4, CD25 and signature transcription factors of these subsets:
Foxp3 and Helios for Tregs and RORc for Th17 cells.
3 Method: Simulation of Treg Dynamics
Ultimately we wish to build a model of the dynamics of Tregs and Th17 cells through-
out life from data currently being collected. Preliminary work for this has involved
building a system dynamics simulation in AnyLogic 6.5.0 University Edition, based
on a mathematical model by Baltcheva [11]. This model was selected as it compre-
hensively incorporates the functional dynamics of Tregs in terms of homeostasis and
during an acute immune response. It characterises the changing precursor and mature
Treg populations throughout the human lifetime. Key assumptions include that there is
no change in function or responsiveness throughout the lifetime, nor a change to other
influential factors on their dynamics such as dendritic cell number and function [11].
Also, the immune response considered includes an expansion and contraction phase,
and only one response can occur at a given timepoint [11]. The original model was based
on numbers of CD4+CD25+CD45RO− (precursor) and CD4+CD25+CD45RO+ (ma-
ture) populations in 119 peripheral blood samples of donors aged 19 to 81 [11]. Al-
though total numbers of CD4+CD25+ cells remained constant, the ratio of precursor to
mature was inverted in early adulthood. This represents an important dimension to the
observed homeostasis in Treg numbers throughout the lifespan, especially when con-
sidering thymic involution from adolescence, reducing the number of new cells entering
the system.
Ordinary differential equations describe the dynamics of the above mentioned cells,
and stochastic processes control the frequency, duration and antigen-specific nature of
primary and secondary immune responses on the different cell compartments [11]. In
this work, a simple scenario was chosen in order to test the hypothesis that the model
could be implemented in AnyLogic. The scenario assumes a lack of antigen-induced
proliferation and death of both precursor and mature Tregs, no density-dependent pro-
liferation and death and thymic output as the only external input into the various Treg
3subsets [11]. The parameter values used correspond to means of the distributions for
scenario 2iiia given in Baltcheva’s work [11]. The simulation is shown below:
Figure 1: Main View. Events are shown with for time in days (t) and years (y). Flow
variables given by involve a rate of conversion multiplied by the number of cells
in the stocks named Y cloneP , −R and −Q. P corresponds to precursors, R to active
matures andQ to quiescent matures. These stocks are prefixed by Y clone as they repre-
sent total and antigen-specific Tregs determined by an array. Homeostatic parameters
apply to the total Treg population, whereas immune response parameters are applied to
a proportion given by piN . For example, flow of specific precursors into the active ma-
ture stock is given by specific precursor stock multiplied by the maturation rate. Each
time point, AnyLogic recalculates each stock using the flows defined.
An additional class (immuneResponse) controls the immune system functional status
using IRstatechart:
Figure 2: immuneResponse View. At the beginning of a run the immune system is in
the NoResponse state. Every 100.95 time steps, the immune system mounts a primary
immune response with probability qt or defaults to a secondary response. PrimaryI
and SecondaryI , represent the expansion phase. PrimaryII and SecondaryII , rep-
resent the contraction phase which continues until a new response is instigated. During
PrimaryI , parameter b is applied. During PrimaryII , b is set to zero and parame-
4ters c, dR and dQ are applied. In SecondaryI parameters b and f are applied and in
SecondaryII these are set to zero and c, dR and dQ are applied.
Figure 3 (generated using MATLAB R2010a): Output data from AnyLogic over a com-
plete run. a) Total precursor and quiescent mature Treg stocks. b) Total active Tregs.
Each peak corresponds to antigen-specific clones experiencing either primary or sec-
ondary immune responses.
Figure 4 shows simulation output compared to the original dataset. Data has been col-
lected for each stock over 3 complete replications. The maximum standard deviation
between three runs for the total precursors was 2.753x10−7. The maximum standard
deviation for total quiescent matures was 9411.
Figure 4: Output data compared to Baltcheva’s dataset. a) The proportion of total Tregs
in the precursor stock. b) The proportion of total Tregs in the quiescent stock.
In order to quantify how similar the simulation output was to the laboratory data, both
datasets were split into 10-year age groups. The median was calculated for these groups,
and the difference between medians for simulation output data and laboratory data have
been documented below. A Mann Whitney test was then performed for the null hy-
pothesis of no difference between laboratory and output data and the p values are given
below:
5Age (Years) Median Difference Mann Whitney TestProportion of
Precursors
Proportion of
Matures
Proportion of
Precursors
Proportion of
Matures
10-19 0.3101 0.0207 p=0.083 p=0.658
20-29 0.0525 0.1092 p<0.001 p<0.001
30-39 0.0290 0.1227 p=0.034 p<0.001
40-49 0.0690 0.1182 p=0.001 p<0.001
50-59 0.0587 0.1007 p<0.001 p<0.001
60-69 0.0072 0.1230 p=0.127 p<0.001
70-79 0.0011 0.1204 p=0.808 p<0.001
80-89 0.0805 0.0775 p=0.014 p=0.014
Table 1: Comparison of median output and laboratory data for each 10-year age
group.
4 Discussion and Concluding Remarks
The implementation of Baltcheva’s model as a system dynamics simulation has been
documented here and compared to experimental evidence. It has been shown that the
simulation mimics the key feature of inversion of precursor and memory cells in early
adulthood. The lack of statistical similarity between simulation output and laboratory
data indicates that further validation of this model is necessary and will involve a com-
parison of other scenarios proposed in Baltcheva’s work. Ultimately we will develop
and validate a simulation of our novel dataset of Treg and Th17 cells using this sort
of approach. CD4+CD25+Foxp3+ and CD4+Foxp3+Helios+ cell numbers instead of
CD4+CD25+s for Tregs will also be collected as they are arguably more specific mark-
ers [12][13]. In terms of improving the simulation, alternatives to continually reactivat-
ing a single Treg clone are required, as is simulation of more than one immune stimulus
at a time. Baltcheva discloses various assumptions including no difference in Treg func-
tion [11]. It may be possible to improve this model by considering functional as well as
numerical changes to Treg subsets with age.
A more abstract research question is whether a simplistic model of immunosenes-
cence can lend useful insight into the biological problem. It can be argued that the
process of simulation alone might allow researchers to address assumptions and allow
for systematic generation of hypotheses. Also, hypotheses which are difficult to test in
the laboratory might be testable with a simulation. For example, we might introduce an
intervention to mimic ablative chemotherapy by depleting each stock at a single time
point. Total values of each stock might then be compared for simulation runs with or
without intervention to make hypotheses about Treg recovery. Simulating the dynamics
of Th17 cells in parallel to Tregs may also allow us to make predictions about the main-
tenance of their balance throughout life, would allow for extreme parameter values to
be tested and may indicate a maximum length of time for homeostasis to be maintained.
Our primary hypothesis is that age alters Treg and Th17 cells with consequences for
health in older age and we aim to conduct a cross sectional study to obtain the distribu-
tion of particular changes. We anticipate that a strategy of both laboratory investigation
6and system dynamics simulation as exemplified by Baltcheva’s work will be useful to
address relationships between T cell subsets over time. The model might also be devel-
oped to consider new questions about response to interventions and the length of time
the immune system might be able to maintain Treg and Th17 cell homeostasis.
With thanks to Irina Baltcheva for providing her raw data.
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